Ajjai Alva
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Molecular Biology top 5%
- Surgery top 2%
- Cancer Research top 1%
- Co-authors
- Helen C. SuMichael J. LenardoSarah J. WelshParmesh DuttEric C. FreundtLi YuEric H. BaehreckeAlon Z. Weizer
- Topics
- Bladder and Urothelial Cancer Treatments (96 papers)Cancer Immunotherapy and Biomarkers (66 papers)Renal cell carcinoma treatment (54 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ajjai Alva
202 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 2.3k
- Oncology 2.0k
- Molecular Biology 1.8k
- Surgery 1.3k
- Cancer Research 1.1k
Countries citing papers authored by Ajjai Alva
This map shows the geographic impact of Ajjai Alva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajjai Alva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajjai Alva more than expected).
Fields of papers citing papers by Ajjai Alva
This network shows the impact of papers produced by Ajjai Alva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajjai Alva. The network helps show where Ajjai Alva may publish in the future.
Co-authorship network of co-authors of Ajjai Alva
This figure shows the co-authorship network connecting the top 25 collaborators of Ajjai Alva. A scholar is included among the top collaborators of Ajjai Alva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajjai Alva. Ajjai Alva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 12 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 28 | |
| 11 | 0 | |
| 12 | 0 | |
| 13 | 58 | |
| 14 | 33 | |
| 15 | 15 | |
| 16 | 5 | |
| 17 | 5 | |
| 18 | 63 | |
| 19 | 86 | |
| 20 | Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8breakdown → | 1023 |
About Ajjai Alva
Ajjai Alva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 218 papers that have together received 5.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (96 papers), Cancer Immunotherapy and Biomarkers (66 papers) and Renal cell carcinoma treatment (54 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Ajjai Alva has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Helen C. Su, Michael J. Lenardo, Sarah J. Welsh, Parmesh Dutt, Eric C. Freundt, Li Yu, Eric H. Baehrecke, Alon Z. Weizer, Maha Hussain and Arul M. Chinnaiyan. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.